Rapigen Inc.

Description: In vitro diagnostic preparations for medical purposes; reagents for use in medical genetic testing; clinical diagnostic reagents for medical or veterinary purposes; chemical preparations for pharmaceutical or medical purposes, namely, for DNA analysis; biological indicators for medical diagnosis for medical or veterinary purposes; medical diagnostic molecular analytes being diagnostic agents for detection and verification of infectious diseases; medical diagnostic test strips for blood analysis, urine analysis, saliva analysis; In vitro diagnostic reagents for scientific purposes; diagnostic reagents for scientific or research use; diagnostic preparations for scientific or research use; reagent, namely, polymerase RNA and DNA formulations for nucleic acid amplifications for scientific or laboratory purposes; chemical reagents for genetic identity testing; chemical solutions and preparations consisting of pre-mixed reactants and reagents for scientific and research use in connection with amplification, analysis, or labeling of nucleic acid for scientific or laboratory purposes; reagents for use in scientific apparatus for chemical or biological analysis; In vitro diagnostic devices being incubators, ultrasound apparatus, cytometers, hematology analyzers, sample preparation devices, apparatus for testing DNA and RNA samples for medical purposes; genetic testing apparatus for medical purposes, namely, real-time gene amplification equipment for medical use; genetic testing apparatus for medical purposes; genetic testing apparatus for medical purposes being miniaturized sensors for use in gene analysis and diagnosis; genetic testing apparatus for medical purposes and apparatus for DNA and RNA testing for medical purposes; diagnostic apparatus for medical purposes used in medical laboratories for testing blood sugar levels, cancer cells, DNA; blood pressure and diabetic diagnostic medical devices; blood containers for medical purposes, sold empty

Description: Medical diagnostic test kits comprised of reagents and assays for testing of bodily fluids for use in detection of COVID-19; Diagnostic testing kits comprised of medical diagnostic reagents and assays that test for the presence of COVID-19; Medical diagnostic kits and equipment, namely, medical diagnostic reagents and assays that test for the presence of viruses and infectious diseases; Medical diagnostics, namely, medical diagnostic test strips for use in detection of viruses and infectious diseases; In-vitro diagnostics, namely, drug test and medical test kits comprised of medical diagnostic reagents and assays for testing body fluids for the detection of COVID-19, malaria, influenza, dengue, hepatitis, adeno viruses, rotavirus, h.pylori, zika, syphilis, HIV, ebola, toxoplasma, chikungunya, and cardiac troponin

Description: Medical diagnostic test kits comprised of reagents and assays for testing of bodily fluids for use in detection of COVID-19; diagnostic testing kits comprised of medical diagnostic reagents and assays that test for the presence of COVID-19; medical diagnostic kits and equipment, namely, diagnostic kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; medical diagnostics, namely, ultrasonic medical diagnostic apparatus; in-vitro diagnostics, namely, Apparatus for DNA and RNA testing for medical purposes